186 related articles for article (PubMed ID: 38834564)
1. Semaglutide ameliorates cardiac remodeling in male mice by optimizing energy substrate utilization through the Creb5/NR4a1 axis.
Ma YL; Kong CY; Guo Z; Wang MY; Wang P; Liu FY; Yang D; Yang Z; Tang QZ
Nat Commun; 2024 Jun; 15(1):4757. PubMed ID: 38834564
[TBL] [Abstract][Full Text] [Related]
2. Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating BNIP3-Mediated mitochondrial dysfunction.
Li X; Luo W; Tang Y; Wu J; Zhang J; Chen S; Zhou L; Tao Y; Tang Y; Wang F; Huang Y; Jose PA; Guo L; Zeng C
Redox Biol; 2024 Jun; 72():103129. PubMed ID: 38574433
[TBL] [Abstract][Full Text] [Related]
3. Semaglutide ameliorates pressure overload-induced cardiac hypertrophy by improving cardiac mitophagy to suppress the activation of NLRP3 inflammasome.
He W; Wei J; Liu X; Zhang Z; Huang R; Jiang Z
Sci Rep; 2024 May; 14(1):11824. PubMed ID: 38782946
[TBL] [Abstract][Full Text] [Related]
4. Ablation of cardiac TIGAR preserves myocardial energetics and cardiac function in the pressure overload heart failure model.
Okawa Y; Hoshino A; Ariyoshi M; Kaimoto S; Tateishi S; Ono K; Uchihashi M; Iwai-Kanai E; Matoba S
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1366-H1377. PubMed ID: 30901275
[TBL] [Abstract][Full Text] [Related]
5. Choline ameliorates cardiac hypertrophy by regulating metabolic remodelling and UPRmt through SIRT3-AMPK pathway.
Xu M; Xue RQ; Lu Y; Yong SY; Wu Q; Cui YL; Zuo XT; Yu XJ; Zhao M; Zang WJ
Cardiovasc Res; 2019 Mar; 115(3):530-545. PubMed ID: 30165480
[TBL] [Abstract][Full Text] [Related]
6. PKM1 Exerts Critical Roles in Cardiac Remodeling Under Pressure Overload in the Heart.
Li Q; Li C; Elnwasany A; Sharma G; An YA; Zhang G; Elhelaly WM; Lin J; Gong Y; Chen G; Wang M; Zhao S; Dai C; Smart CD; Liu J; Luo X; Deng Y; Tan L; Lv SJ; Davidson SM; Locasale JW; Lorenzi PL; Malloy CR; Gillette TG; Vander Heiden MG; Scherer PE; Szweda LI; Fu G; Wang ZV
Circulation; 2021 Aug; 144(9):712-727. PubMed ID: 34102853
[TBL] [Abstract][Full Text] [Related]
7. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
8. A novel traditional Chinese medicine ameliorates fatigue-induced cardiac hypertrophy and dysfunction via regulation of energy metabolism.
Huang R; Cui YC; Wei XH; Pan CS; Li Q; He SY; Fan JY; Han JY
Am J Physiol Heart Circ Physiol; 2019 Jun; 316(6):H1378-H1388. PubMed ID: 30951366
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-mediated inflammatory signaling reprograms cardiac energy metabolism by repressing peroxisome proliferator-activated receptor γ coactivator-1 signaling.
Schilling J; Lai L; Sambandam N; Dey CE; Leone TC; Kelly DP
Circ Heart Fail; 2011 Jul; 4(4):474-82. PubMed ID: 21558447
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Overexpression of PDE4B Blunts β-Adrenergic Response and Maladaptive Remodeling in Heart Failure.
Karam S; Margaria JP; Bourcier A; Mika D; Varin A; Bedioune I; Lindner M; Bouadjel K; Dessillons M; Gaudin F; Lefebvre F; Mateo P; Lechène P; Gomez S; Domergue V; Robert P; Coquard C; Algalarrondo V; Samuel JL; Michel JB; Charpentier F; Ghigo A; Hirsch E; Fischmeister R; Leroy J; Vandecasteele G
Circulation; 2020 Jul; 142(2):161-174. PubMed ID: 32264695
[TBL] [Abstract][Full Text] [Related]
11. Dipeptidyl Peptidase 4 Inhibition Alleviates Shortage of Circulating Glucagon-Like Peptide-1 in Heart Failure and Mitigates Myocardial Remodeling and Apoptosis via the Exchange Protein Directly Activated by Cyclic AMP 1/Ras-Related Protein 1 Axis.
Aoyama M; Kawase H; Bando YK; Monji A; Murohara T
Circ Heart Fail; 2016 Jan; 9(1):e002081. PubMed ID: 26721911
[TBL] [Abstract][Full Text] [Related]
12. Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt.
Sun Z; Zhang L; Li L; Shao C; Liu J; Zhou M; Wang Z
Am J Physiol Heart Circ Physiol; 2021 Jan; 320(1):H364-H380. PubMed ID: 33275526
[TBL] [Abstract][Full Text] [Related]
13. Obesity-induced cardiac lipid accumulation in adult mice is modulated by G protein-coupled receptor kinase 2 levels.
Lucas E; Vila-Bedmar R; Arcones AC; Cruces-Sande M; Cachofeiro V; Mayor F; Murga C
Cardiovasc Diabetol; 2016 Nov; 15(1):155. PubMed ID: 27832814
[TBL] [Abstract][Full Text] [Related]
14. Glucagon-like peptide-1 receptor activation reverses cardiac remodeling via normalizing cardiac steatosis and oxidative stress in type 2 diabetes.
Monji A; Mitsui T; Bando YK; Aoyama M; Shigeta T; Murohara T
Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H295-304. PubMed ID: 23709595
[TBL] [Abstract][Full Text] [Related]
15. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
[TBL] [Abstract][Full Text] [Related]
16. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
17. The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure.
Beak JY; Kang HS; Huang W; Myers PH; Bowles DE; Jetten AM; Jensen BC
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H186-H200. PubMed ID: 30387679
[TBL] [Abstract][Full Text] [Related]
18. Diabetic db/db mice do not develop heart failure upon pressure overload: a longitudinal in vivo PET, MRI, and MRS study on cardiac metabolic, structural, and functional adaptations.
Abdurrachim D; Nabben M; Hoerr V; Kuhlmann MT; Bovenkamp P; Ciapaite J; Geraets IME; Coumans W; Luiken JJFP; Glatz JFC; Schäfers M; Nicolay K; Faber C; Hermann S; Prompers JJ
Cardiovasc Res; 2017 Aug; 113(10):1148-1160. PubMed ID: 28549111
[TBL] [Abstract][Full Text] [Related]
19. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
20. Plin5 deficiency exacerbates pressure overload-induced cardiac hypertrophy and heart failure by enhancing myocardial fatty acid oxidation and oxidative stress.
Wang C; Yuan Y; Wu J; Zhao Y; Gao X; Chen Y; Sun C; Xiao L; Zheng P; Hu P; Li Z; Wang Z; Ye J; Zhang L
Free Radic Biol Med; 2019 Sep; 141():372-382. PubMed ID: 31291602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
